Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Flu Vaccine Tax Should Take Effect In July 2005, HHS Commission Says

This article was originally published in The Pink Sheet Daily

Executive Summary

Complications resulting from the current flu vaccine shortage would make it difficult to add trivalent influenza vaccines to the Vaccine Injury Compensation Program in December, commission members say. HHS appears likely to follow the commission’s recommendation.

You may also be interested in...



Guaranteed Purchase Of All Doses Could Attract Flu Vaccine Makers, Wyeth Says

Guaranteeing that all flu vaccine doses produced will be purchased is the most significant way Congress can create incentives for manufacturers to re-enter the flu vaccine market, Wyeth VP-Scientific Affairs Peter Paradiso, PhD, said Nov. 16

Guaranteed Purchase Of All Doses Could Attract Flu Vaccine Makers, Wyeth Says

Guaranteeing that all flu vaccine doses produced will be purchased is the most significant way Congress can create incentives for manufacturers to re-enter the flu vaccine market, Wyeth VP-Scientific Affairs Peter Paradiso, PhD, said Nov. 16

Excise Tax On Flu Vaccine Added By Congress

Flu vaccine appears close to inclusion in the Vaccine Injury Compensation Program after Congress' approval of an excise tax on the vaccine

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS058105

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel